TCRX Competitors & Alternatives
Compare Tscan Therapeutics Inc with similar stocks in the same industry
Biotechnology
TCRX
Main Stock$0.32
Tradestie Score
59
Market Cap
$118.60M
Revenue Growth
-0.7%
Analyst Upside
+212.0%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.92
|
$154.27M | - | 68 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.94
|
$133.50M | - | 52 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.73
|
$114.01M | - | 44 | Compare |
|
SERA
Sera Prognostics, Inc. Class A Common Stock
|
$2.09
|
$112.28M | - | 51 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.80
|
$110.20M | - | 61 | Compare |
|
ABOS
Acumen Pharmaceuticals, Inc. Common Stock
|
$2.04
|
$106.00M | - | 46 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.86
|
$84.52M | - | 59 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$9.68
|
$67.94M | - | 45 | Compare |
|
IPSC
Century Therapeutics, Inc. Common Stock
|
$1.53
|
$43.18M | - | 37 | Compare |
|
INAB
IN8bio, Inc. Common Stock
|
$1.40
|
$10.26M | - | 33 | Compare |
More TCRX Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry